The chemist and druggist [electronic resource]

52 Pages·2001·8.5 MB·English

by  UBM

1P Chemist Druggist
lessMedia
ne NewsweeKiv Tor rnsrinscv
I
PSNC
threaten
legal action on
dispensing fee
Wales
calls for
action on poor
checks
script
PI usage set to
OT(a+<"* Junior Crea(*. by 120pc
rise
^e* to their i+cAy, <ky rfcin over five years
Shortages of
generics a
still
danger
real
SOOTHES
Oilatum Junior Cream Oilatum
effectively and, being fragrance free, is
gentle on the sensitive skin of children CREAM
and babies While it REHYDRATES 1
it creates an emollient barrier on the skin
HVMATCSI
PROTECTS
that aga,nst further
drying-Andasyou'dexpectofanOilatum
skin treatment, our Junior Cream is •1
suitable for eczema. For leaflets and
FREE SAMPLES,
call SUefel
Laboratories on 0800 783 6699.
www.oilatum.co.uk tAake i+ yoor recover)da+roio.

1
STAND UP TO
FOOD ATTACK
For sufferers ofheartburn and indigestion,
it can take no more than a simple meal for
a painful attack to start.
Now you can get tough with difficult food.
Arm your customers with Zantac 75 and good
advice, and let each small tablet work quickly HEARTBURNSINDIGESTIONRELIEFFORUPTO12HOURS
to fight excess acid and keep food friendly
ranitidine (as HCI)
all through the day or night.
A force for comfort
Zantac75Relief12'sProductInformation confusion,depression,hallucinations,involuntarymovementdisorders,changesin
Presentation: each tablet contains 75mg ranitidine Uses: Symptomatic relief of liver function tests, hepatitis, jaundice, acute pancreatitis, leucopenia,
heartburn, indigestion, acid indigestion and hyperacidity. Dosage and thrombocytopenia, agranulocytosis, pancytopenia, marrow hypoplasia, aplasia,
Administration:Adultsandchildrenaged16andover,onetablet Nomorethantwo hypersensitivity reactions, bradycardia.A-V block, skin rash, vasculitis, alopecia,
tabletsshouldbetakeninany24-hourperiod Contraindications:Hypersensitivity musculoskeletalsymptoms,impotenceandbreastswelling/discomfortinmen.See
Precautions:Treatmentshouldberestrictedtomaximumof6dayscontinuoususe SPCforfurtherdetails LegalCategory:GSL RetailSellingPrice(exVAT):Zantac
atanyonetime.Patientsshouldcontacttheirdoctoriftheirsymptomsdonotimprove 6's£1.69,Zantac 12's£331. ProductLicenceNumber: PL10949/0313 Licence
after6dayscontinuoustreatment.Shouldnotbetakenbythefollowinggroupsof Holder:GlaxoWellcomeUKLimited,StockleyParkWest,Uxbndge,Middlesex,UB1
patients unless under medical supervision: those with difficulty swallowing, 1BT. Further information available on reguest from: Medical & ConsumerAffairs.
persistentstomachpainorunintendedweightloss;thosemiddleagedorolderwith GlaxoSmithKline Consumer Healthcare, Wallis House, Great West Road. Brentford
new or recently changed symptoms of indigestion; during pregnancy or in those TW8 9BD Date of preparation: May 2001 ZANTAC 75 RELIEF and ZANTAC 75
tryingtobecomepregnant,orbreastfeeding;thosetaking DEVICEareregisteredtrademarksoftheGlaxoSmithKlineGroupofCompanies
fL- NSAIDs or with a history of porphyria Side Effects:
^Jpraa/rosmithKiine Generally well tolerated. Rarely headaches, dizziness, ©GlaxoSmithKline,2001
.
Prescribing Information (PI)
fpiease refei to the full 5PC
befoie pres<ribing)
Ifoan 150 mg
prolonged release tablets FOR SMOKING CESSATION
(bupropion HCI)
Uses Smoking cessation (with motivational
saunpdpoardtm)iinninsitcroattiinoen-dMeuplelnsdefnrtopmatiWentysi..Dosage Z MARKS THE SPOT
treatmentwhilestillsmokingandset'targetstop
date' insecondweek. 150mgod. for6days
then150mgbd.forremainderof7to9week
course.Maximum150mgsingledoseand300mg
daily Allow ar least 8 hours between doses.
Swallow tablets whole - do not crush/chew.
Discontinueifnoeffectatweek7 Elderly, renal
ormild-to-moderatehepaticimpairment. 150mg
d Contra-indicationsHypersensitivity,curreni
seizuredisorder/historyofseizures,CNStumour,
abrupt alcohol/benzodiazepine withdrawal,
current/previous eating disorder, severe hepatic
cirrhosis,recent/currentMAOIs.bipolardisorder
Precautions Predisposition to lowered seizure
threshold/increased risk of seizures (includes
previoushead injury,othermedications, alcohol
abuse, diabetes, use of stimulants/anorectic
products) - u^e only if the medical benefit of
stoppingoutweighstheincreasedriskofseizure-
considerusing 150mgo.d. forthesepatients;
renal or mild-to-moderate hepatic impairment,
eldetly;susceptibilitytopsychoticepisodes Drug
interactions Theophylline, tricyclics. SSRIs,
MAOIs, antipsychotics, beta-blockers, class 1c
antiarrhythmics, enzyme inducers/inhibitors.
orphenadnne, cyclophosphamide, levodopa.
antimalarials, tramadol, qumolones, sedating
antihistamines Pregnancy and lactation Not
recommended Side effects Common dry
mouth, gastrointestinal pain/upset, insomnia,
tremor, concentration disturbance, headache,
dizziness, depression, agitation, anxiety, rash,
pruritus,urticaria,sweating,fevertastedisorders
Uncommon chest pain, asthenia, tachycardia,
blood pressure changes, flushing, confusion,
anorexia,tinnitus,visualdisturbance.
Rore: vasodilation, syncope, seizures, irritability,
hostility,severehypersensitivityreactionsincluding
anaphylaxis, arthralgia, myalgia and fever,
erythema multiforme. Stevens Johnson
syndrome.Discontinueifseizure,hypersensitivity
reaction or anaphylaxis occurs Presentation
and basic NHS cost 60 tablet'. £42.85
Product licence (PL) no. PL10949/0340
PLholderGlaxoWellcomeUKLtd..StockleyPark
West,Uxbndge.UB11 IBT
POM
1 I
Furtherinformationisavailablefrom:
Customer Contact Centre. GlaxoSmithKlme,
StockleyParkWest,Uxbndge.MiddlesexUB11 1BT.
E-mail,[email protected]
wwwthetimeistight.co.uk
wwwright-time.co.uk
wwwzyban.co.uk
Freephone:0800221441
©GlaxoWellcomeUKLimited,2001
ZybanandtheZybanlogoaretrademarksofthe
GlaxoSmithKlmeGroupofCompanies
References
1. LeshnerAl HospPract1996;Oct15 47-59
2. Ferry LH. Prim Care Clin Off Pract 1999;
26:653-669. Nicotine addiction is a neurobiologically-mediated brain disease.1 Zyban is a uniq
3. Covey LS, Sullivan MA,JohnstonJA, el ol
Drugs2000;59(1) 17-31. non-nicotine tablet therapy that works in the brain by acting on the neurotransmitt
involved in nicotine addiction and withdrawal.23
GiaxoSmithKiine
bupropion HCI SR
Science against smoking
GEN 26847/A-September2001
7
;
Contents,
Chemist&
Druggist
The Newsweekly
Pharmacy
for
Editor
PatrickGrice,MRPharmS
AssistantEditor Volume 256 No 6320
GuyL'Aimable,BA
NewsEditor 1 42nd year of publication
CharlesGladwin,MRPharmS ISSN 0009-3033
BusinessEditor
NinaKeller-Henman,DiplBiol
ContributingEditor
AdriennedeMont,FRPharmS
MarketingEditor
SarahThackray
Reporters PSNC: legal action on dispensing fee?
VGaanreysPsaaraSgphuerriw,oModR,PhMaRrPmhSarmS ThePharmaceutical ServicesNegotiatingCommitteemayseeka judicial
ArtEditor reviewovertheIlealth Minister'sdecision toreducethedispensingfee
TonyLamb
PrFoadyuJcotnieosn,EBdAitor Bid for pharmacy consortia in care centres
ProductionSub-Editor TheNPAwantsnew primarycarecentrestogiveallaffected proprietorsthe
LorriPimlott chancetojoinaconsortium there
Editorialsecretary
JanPowis
Editorial(tel):01732377487; Welsh get tough on script checks
c(fhaxe):m0d1r7u3g2®3c6m7pi0n6f5o;rmation.com TheAuditCommitteeoftheNational Assembly forWaleshascalled for
PriceList toughersanctionsagainstpharmacistswhoconsistently failtocheck
ColinSimpson(Controller), prescriptionexemptions.
DarrenLarkin,MariaLocke
PriceList(tel):01732377407
(fax):01732377559 For she's a jolly good fellow...
GroupAdvertisementManager
JuliandeBruxelles C&D'scontributingeditorAdriennede Monthasbeen
GroupAdvertisementExecutives madeaFellow ofthe Royal Pharmaceutical Society for
QuentinSoldan,MarkWailey distinction in theprofessionofpharmacy
ClassifiedExecutive
DebraThackeray
Advertisementsecretary Parallel imports likely to rise 12 Question time 6
AE(fdlaavxi)e:nret0iS1sti7en3eg2l(et3el7):701177932377621 P1r2i0cepefrluccetnutatoivoenrstahnednoetxhtefrivfeacyteoarrss,wiclllaidrmisvReeuuptetrhseBvuasliuneeosfsPIInsiinghEturopeby Coming Events 13
Production
KatrinaAvery NICE recommendations obligatory in 2002 Opinion 16
PublishingDirector
SpFSetecerivgaeulsBPWrrieolmjseeorcntMsRMPahnaargmeSr HtthrAeeisartamgenenndetrPsaClfTraosnmnwuJiaalllnuhaaalrlvyoecatlth.irToehnesemywohnwiitclhlhsbcetoouelfxdipnemdcetfaeudnndtbioundmggeefeottrctNuhItesCceoElstsasepwophuretorveoefd XMraarykseetrw1atch 30
©CMPInformationLtd
Chemist&DruggistincorporatingRetail
Chemist,PharmacyUpdateandBeaut} Letters 46
Counter
PCuMblPisIhnefdoSramtautridoanyLstbdy, Food for thought Classified 47
SovereignWay,Tollbridge,
KentTN91RW ContinuingherBodyBasicsseries, FawzFarhanexplainshownutrientsare Back issues 50
C&Dontheinternetat: metabolised bv thebody
http:/A\\\udotpharmacvcom/
Subscriptions:(Home)£140perannum,
(Overseas&:hire)S345perannumincluding
postage,£1Mlpercopy(postageextra)
AdditionalPriceList,£78perannum
Circulationandsubscription:
CMPInformationLtd,TowerHouse,
SHoavrebroeriogunghPa,rkL,eiLcsa.thLkiEll16St9,LMFarket A level playing field for all 36
Telephone:[phone] LPCsshouldavoid gettinginvolvedinredesigninglocal pharmaceutical
Fax:[phone] services,saysDrDarrinBaines
Refundsoncancelledsubscriptionswillonlyhe
providedatthe-publisher'sdiscretion,unless
sspuebcsicfriciapltliyonguoaffrearnteedwithinihetermsof For generics no system is perfect 39
Theeditorialphotosusedarccourtesyofthe Themaximum priceschemehas undoubtedlyhadsomesuccess,butis
supplierswhoseproductstheyfeature italong-termsolution?NinaKeller-Henmantakesalookatwhat's
happeninginthegenericsmarket
•••• ••
•• •• In the year 2020... 45
CMP Michael Barbour, winneroftheUniChemYoungPharmacistBusiness
Award 2001, looksaheadtothe futureofpharmacy
UiiiI'mJP.ti:;iiiev,Mwli.i
Chemist-Druggist 8 December2001 S
Thisweek
w
PSNC APPOINTMENTS
PSNC
threatens Pharmacists
CSM
on the
action over fees DrTerenceMaguire from
Northern Ireland hasbeen
appointed totheCommitteeon
SafetyofMedicines,alongwith
Alison Blenkinsopp, Professorof
The Pharmaceutical Services sumsystemofpayment. This thatsetsareasonable fee." PracticeofPharmacyatKeele
Negotiating Committee has required hertorecoverthe Therewas"absolutelyno University, whowasre-appointed.
invited the Health MinisterHazel overpaymentmadetocontractors dissent" within theCommittee DrMaguirerecentlystooddown
Blearstoreview herdecisionto causedby lastyear'sprescription aboutthecourseof actionthatis asdirectoroftheNorthernIreland
reducethedispensingfeeto87.4p volume increases. beingtaken, sheadded. PSNC CentreforPharmacyPostgraduate
from November 1. Ifshedoesnot PSNCsaystherearenobinding canafforda legal challenge EducationandTraininginOctober
dosothen PSNCintendstoseek rules. The global sumsystemisa withouthavingtoseekadditional (seeC&D, Oct6,p4).
a judicialreview. meansby whichasumofmoney funds from LPCs. • LordHuntalsoannounced that
InalettersenttoMsBlears last tofund thecommunity pharmacy The Company Chemists PeterNoyce, Professorof
Friday, PSNC"invited" the dispensingsystemiscalculated. Association hasgiven its PharmacyPractice, Universityof
ministertoacceptthather "It hasnot been specified within unanimoussupport tothePSNC. Manchester, hasbeenappointedto
decision wasbeingmadeona legislationand thereforeministers DigbyEmson,chairmanof the theMedicines Commission.
fundamentally flawed basis. She arenotboundtocomply with it." CCA,said: "TheCCAsupports
hDaescbeemebnergi2v8entoardeesapdolnidne.of exeScuuetivSeh,arspaeid,:P"SWNeChsopcehitehfat tsheeekPinSgNtCosenascutrievitthyaitnctohnitsraacrteoarisn' Rise in ESPS
AtameetingwithPSNCin shewillrecognisethatthe additional workload isbeing payments
mid-NovemberandattheNPA disastrousdecisionshemadewas assessed fairly."
dinnerlastweek (C(5DDecember reachedonafalse understanding
/,p6) MsBlearssaidshewas ofherpositionandthatwe Formoreinformation: Theannual target payment forthe
boundby the rulesoftheglobal canexpectarevised decision www.psnc.org.uk 287 contractorsintheEssential
\
Small PharmacySchemehasrisen
SURVEY
to£40,350for2001-02, in line
Young people at risk Complaints with the global sum.
Thequalifyingthreshold isnovvi
23,040prescriptionsand the
leaflet
Smoking, drinkinganddrugs alsoroseto24percentin 2000. maximum monthlypaymentis
misuseamongyoungpeople This figureroseagain withageto £2,900. Tomaketheback
increasedbetween 1999and 2000, 49percentof 15 yearolds. TheHealth ServiceOmbudsman's paymentfrom April, the
accordingtoanational surveyof ClassA drugusageamong office hasrevised itsinformation maximum monthly payment
7,000schoolchildrenaged 11-15 pupils wasalsohigherat9per leaflet, givingdetailson how to will increaseto£3,870 for
published bv theDepartmentof cent. However, cannabiswasthe makeacomplaint. A form helps December.
Health. most likelydrugtobeused. Some complainantsputtheircasein
Theproportionofpupilswho 28percentof 15 yearoldssaid writing The leafletisavailable in This month's
smoked at leastonecigarettea theyhad useditinthelastyear. severalethnicminority languages. Update question
weekincreased to 10percentin Although6percentsaid they Braille,audiocassetteand large
2000,a riseof 1 percentfrom had beenoffered heroinor print paper enclosed
1999. Smokingalsoincreased methadone,only 1 percenthad
sharply withage, with23 percent used them. Formoreinformation: Enclosedin this
of 15 yearoldssmokingregularly. Tel:[phone] week'sissueis
Thenumberof pupils whohad Formoreinformation: E-mail:OHSC.Enquiries@ombudsman. thequestionnaire
drunkalcoholin thepreviousweek www.doh.gov.uk gsi.gov.uk (2217)forthe
following
Pharmacy
Questiontime Updatemodulescarriedin
November:
•
ExploringCandida (1217)
The Royal Pharmaceutical Society is •Thedigestivetract(1218)
proposing to close the museum as part of Whatyou.toldus: Ovariancancer(1219)
its budgetary cuts. Do you support this % PharmacyUpdateisadistance i
move? 100 learningprogrammeaccredited
zo bytheCollegeofPharmacy
®Yes ®No ®Don'tknow 80 83% Practice. Previousmodules
Youcanrecord yourvoteonourwebsitf.irwip.ciotphcirmacy.com. On canbeobtainedbyusingthe
thehomepageyouwill findalinktotheQuestionTimepage. Select faxbackserviceon08705
60
youranswerandthenclickonthe"vote"box. Youransweris 441188oraccessingthe
Yauotuomhaatviecaulnltyilconloloatnedo.nDecember 11 tocastyourvote. Wewill 40 1OC dwrovtwP.hdaortpmhaacrymawceyb.sciotme.at
publishtheresultin C&D,December 15. >CCOD J* ThePharmacyUpdate
20 Q"Oc ij multiplechoicequestionnaire
Lastweekweaskedyou: 0% and telephonemarkingservice
DoyoustillhaveconfidenceinthePSNCasanegotiatingbodyafter i i aresupported byGenus
therecentpayimposition? Pharmaceuticals.
6 8 December2001 ChemistsDruggist
Thisweek
Back to school with
Lloydspharmacy
Lloydspharmacyisinvestingover
£20,000toprovide20ofits
pharmacistswithanopportunityto
undertakeapostgraduate
medicinesmanagement
training programmeatKeele
University.
Thedistancelearning programme
startsin Decemberand provides
pharmacistswithanunderstanding
ofmedicinesmanagementand
pharmaceuticalcare.
Thecompanyispayingforcourse
fees, locumcostsandtravelling
expenses. Lloydspharmacyis
investigatingfurtherlearning
opportunitiesfornextyear.
Drug recall by
Aventis
Furthertothedrug recallissued by
AventisPasteurMSDon November
20(C&D, November24, p5)the
GSK'sveryownCoventGarden:thecompany'snew93,000m2corporateheadquarters ismadeupbythreefive- companyisrecallingallremaining
ssttroereetyibnucilluddiengasLloinnkdeidsbsytoare1,4a2hmai"rsdtrreeseste"r.,Itbaanlks,oidrnyclculdeeasnaer1a6n-sdtoarheeyaclatrhpaanrdkifnitgntesoswecre.ntFraeci.liAtipehsaarlmoancgythies, abantdPcaphtaieeesdnitoasftrVwiahcq.otahaivnjeecrteiconesi,veaddutlhte
however,conspicuouslyabsent.GSKstaffarebeingmovedintothenewpremisesinstagesuntil March2002 vaccineshould beadvisedto
contacttheirdoctorasthey
maynothavereceivedadequate
NPA backs study Private-Rx protectionagainsthepatitisA.
PTC website sold Formoreinformation:
on consortias Tel:[phone].
to economist NHS
Interactive
TheNational Pharmaceutical leading topostcode variationsin enquiry service
Association's Board hasagreed standards. Private-Rx, thepharmacist-only
thatapaperbeprepared setting TheBoardagreed therewasa ' website, hasbeensold to I)r Anew-look NHS DirectOnlinesite,
ocuotnstohreticaasien fporrimpahrayrmcaarceycentres. niemepdlefmoernctoerdesntatainodnaarldlsy,tsoobtehe I)aSririmnonBaiWnheist,akaehre,alptrhopercioentoomriosft. wsehrivciche,inicslnudoewsaunpianntderarcutninvienge.nquiry
TheNPAbelievesthatwhena NPA will producearesource the site,said that it hadbecomeso Pheaatlitehntesnaclyscolohpaaveediaaccoefsosvetora40n0ew
newprimarycarecentreisbuilt,all pack for PC"Isand health busy itwasnolongerpossible to topics.
affected proprietorsshouldbe authorities. run it in hisspare timeand it •Hazel Blears, healthminister, has
giventhechancetojoin a PCTmembers' task force wasachoiceofclosingorselling announcedafourthpilot, toprovide
consortium in thecentre. There TheNPA,CompanyChemists the site. healthinformationthroughdigital
should notbeamonopolyinwhich Associationand Pharmaceutical Dr Baines, directorof medM, interactiveTVtoviewersin Hulland
onecontractorcouldpayforthe ServicesNegotiatingCommittee confirmed that Private-Rx EastYorkshire.
exclusiverighttooperatethere. haveorganisedameetingfor would remain "exclusive,
AttheNovembermeeting. pharmacist membersof PCT independentand free". He Formoreinformation:
Board members wereconcerned executiveboardstodiscussways said that hismotivation for www.nhsdirect.uk
thatpharmaciesshould notbe thatpharmacyorganisationscould buyingthesite was not OFT
forced outofbusinessinthisway. support them. commercial. "Asanacademic control of entry
Itwasin the public interest for Monitoringofadvertising I can see the valuein things like survey
pharmacyownerstoco-operate The Pharmaceutical Groupofthe this."
withoneanotherandsoprovide European Union intendsto He alsoconfirmed that there TheOfficeofFairTrading (OFT) is
thebestpossiblearrangements for monitora five yearpilot in which willbe nochangesto thesite consulting pharmacistsaspartofits
thepublic. manufacturerswillbeableto | unlesstheyareapprovedby the ongoingreviewofcontrolofentry
TCohsetNsPofAcilsicnoincaclergnoevdearsntaonhceow pPrreosvcirdieptiinofnorOmnaltyioMneodniccienretsain I sctaenerei-nmgaiclomDmritBtaeien.esPeople TareshgkeuilnOagtFipTohnsha.ramsaicsissutesdaaboquutestthieonlniakeilrye
ccloimnimcualnigtovyeprhnaanrcmeacsytractoeuglidesbfeor dirTehctelyPtGoEthUe pauibmlsict.omakesure wweibtshitaen.ysuggestions forthe airmpraacntgeomnenptastiwenetrseifttohbeeexriesltaixnegd.
implemented withoutadditional that theoutcome isin thebest Therearecurrently justover Italsoincludesaseriesofquestions
funding. interestofthepatientand that 1200 pharmacistsmembersof relatingtoturnoverandopening
TheNIIS guidelinessuggest onlyaccredited informationis Private-Rx. hours.
that"healthauthoritiesand PC.Is available. The group would also
s\hPoAuld(bionuvgehsttatchcisorcdoiunlgdlyb"ebutthe odiprpeocstetoancyonpsroupmoesraladtvoeratllioswingof I wFwowr.pmroirvaetei-nrfxo.rcmoa.tuikon : wFworw.mooftr.egoivn.fuokrmation:
interpreted in different ways, POMs. E-mail:[email protected]
CO
ChemistSDruggist 8 December2001 7
Thiswcck
N Ireland to Pharmacists Wales face
in
opt with
in
UK sanctions on script checks
rest of
CRHP
under
TheAudit Committeeofthe somepharmacistsarenot ® Providingbetterinformationtc
National Assembly forWaleshas checkingexemptions fullycould pharmacistsaboutpatient
ThePharmaceutical Societyof called fortoughersanctions bebecausetheyareunwillingto exemptioncriteria.
Northern Ireland'sCouncil has against pharmacistswho damagetheirrelationship with O Havingabetterdefinitionof
decided itisbettertojoin withthe consistently fail tocheck patients. Italsosuggestthatthe thestandardof performance
UK
restofthe overprofessional prescriptionexemptions. criteriaforexemptionistoo expected from pharmacistsin
self-regulation, ratherthan going Thecall forsanctionswas complicated. assessingentitlementto
italone. prompted by itsreport, CommunityPharmacyWales, exemption.
TheCouncil thinksthe MaximisingIncomefrom whichofferedevidencetothe OHavingamoreeffective
UK
advantagesofcoming under Prescription Charges, in which the Assemblyin defenceof incentive forpharmaciststo
legislation faroutweigh the AssemblysaystheNHS in Wales pharmacists,said: "Abusy dischargetheirpointof
disadvantages. Membersagreedat could belosing£15 millionayear pharmacyisadifficult dispensingresponsibilities.
theOctobermeetingthat it would becausepatientsarereceivingfree environmentin whichtocarryout 9 Havingsanctionsagainst
beapositivemovetobe included prescriptionswhentheyarenot pointofdispensingchecks, pharmacistswhoconsistently fail,
UK
intheproposed Council for entitled tothem. Income from particularlywhenapatientisnot incheckingexemptionsproperly.';
theRegulationofHealthcare prescription chargesisestimated prepared toco-operate."
Professions(CRHP). Ifnecessary, at£23mfor2000-01 Keyareasidentifiedbythe Formoreinformation: I
PSNIcould light forautonomy Thereportsaysthereasonsthat report whereaction isneeded are: www.wales.gov.uk
from within.
Although Northern Ireland is
notmentioned in theconsultation NPA
documentModernisingthe The supervision debate: there must be
Regulationof Healthcare
Professions, itisextremely unlikely no relaxation of legal rules, says NPA
thataparallelsystem wouldbeset
up fortheprovince. IfN Irelandis
notincluded, primarylegislation TheNational Pharmaceutical thatthereshould benorelaxation debatemusthighlightpublic
takingoneortwoyearswould be Association haswelcomed the ofthecurrent legalsupervision safety asapriority. During
neededand there would be newsthattheRoyal requirements,asinterpreted in dispensing,everyprescription
questionsofparitywith Pharmaceutical Societyisto theCodeofEthicsand shouldbeseenatleastoncebya
pOhaArmqaucoisrtusminwaGsrenaottBrreiatcahine.dat re-TohpeenNtPhAessuuppeprovritssiotnhedebate. ProAfnesysimoonvaleSttoadnodatrhdisswdooucludmebnet. apshsaersmsamceinsttcsaonthbaetcaarprrioefdesosuito.nalI
the Society'sannual meetingon Society'sviewthatpharmacists ofgreatdetrimenttothe I'he NPA saysa pharmacist
October 18, sofourproposed mustbe freed fromthe profession,bothnationallyand mustbeonthepremisesatall
changestotheCodeofEthics mechanical aspectsofdispensing internationally, itsays. timeswhenprescriptionsare
could notberatified. A further tospendmoretimewith patients. TheNPABoarddecidedatits dispensed,orwhen Pharmacy
specialmeetingwillbeneeded. Butthe Association isadamant Novembermeetingthatanv medicinesaresold.
O WesternHealth&Social
ServicesBoard hasturned downa
furtherrequest forfinancial
supportfortheMcBrienand
McSorley Statutory Committee
inquiry,suggestingthatPSNI
should recoupthedeficit.
Clarifyingtheresourcingof
such inquiries, MrsMaltbysaid
PSNIonlypaid forcasesit
broughtbeforetheStatutory
Committee;otherpartieshad to
payforcasestheybrought. Itwas
agreed thatall casesshould be
broughtbeforeCouncilbefore
beingreferred totheStatutory
Committee.
'] In I.thics and ! ,a\\ ( Committee
isexploringissuessurrounding
mandatory continuingprofessional
development.
•
Reciprocalregistration was
approved forMissShauna SeventeendispensershavebeenawardedtheBootsDispensingDistinctionAward,forachievingmorethan90
O'Brien, 21 Hereford Place, percentintheirexamsandcoursework,DigbyEmson, pharmacysuperintendent,presentednineofthewinners
Cheltenham,GloucsGL504JQ, withtheirawardsatBootsheadofficerecently. Fromlefttoright: DigbyEmson,pharmacysuperintendent,Nick
•DrTerry Maguirewasco-opted RyanandDeniseBriggs(professionaldevelopment),LizNewby(contractmanufacturingspecials), LyndseyMutcl
to fillMthe vacancyonCounciland AlanSare(development),PamHedges,AnneSorrell,JoanChilton(development),SandraPeel, PaulRead,
Mrs Singletontofillavacancy RebeccaRoss,JulieBrereton,SteveChurton(assistantpharmacysuperintendent),LesleyHall,DerekWebb,and
on theStatutoryCommittee. coursetutorEffiePitsillides
December2001 Chemist:<Druggist
WWHAM-Y
new NUROF6N
PHARMACY
ONLY
MAXIMUM
STRENGTH
TARGETEDRELIEFFORPAIN
0%
double strength ibuprofen
(1
Product information. Nurofen Gel Maximum Strength: years ofageexcept on theadviceofa doctor Precautions a)non-specificallergicreactionandanaphylaxis,b)respiratory
Gel for topical administration containing ibuprofen 10%w/w andWarnings:Applywithgentlemassageonly.Avoidcontact tract reactivity comprising of asthma, aggravated asthma,
Indications: For the relief of pain and Inflammation with eyes, mucous membranes and inflamed or broken skin bronchospasm or dyspnoea, or c) assorted skin disorders,
associated with backache, non-senous arthritic conditions, Discontinue if rash develops. Hands should be washed including rashes ofvarious types, pruritis. urticaria, purpura,
rheumaticand muscularpain, sprains, strains, sportsinjuries immediately after use. Notfor use with occlusive dressings angiodemaandlesscommonly,bullousdermatoses(including
andneuralgia. Dosage:Adults,theelderlyandchildrenover Thelabelwillstate Donotexceedthestateddose Keepout epidermal necrolysis and erythema multiforme). Gastro-
14years.Squeeze2to5cmofthegel(50to125mgibuprofen) ofthe reach ofchildren Forexternal use only Ifsymptoms intestinal abdominal pain, dyspepsia Product Licence
from the tube and lightly rub into the affected area until persistconsultyourdoctororpharmacist.Donotuseifyouare Number: PL 10972/0082 Licence Holder: Goldshield
absorbed Themaximumnumberofapplicationsof5cmgelin allergicto ibuprofen oranyofthe ingredients, aspirin orany Group PLC (trading style. Goldshield Pharmaceuticals).
any24hoursisfourWashhandsaftereachapplication.The other painkillers. Consult your doctor before use if you are NLA Tower. 12-16 Addiscombe Road, Croydon CR0 OXT
doseshouldnotberepeatedmorefrequentlythaneveryfour takingaspirinoranyotherpain relieving medication,youare LegalCategory:P Price:MRRP£525 Dateofpreparation:
hours. Do not exceed the stated dose Review treatment pregnant Notrecommendedforchildrenunder14years Side June 2001. Distributed by
after2 weeks, especially ifthe symptomsworsen or persist Effects: Hypersensitivity reactions have been reported Crookes Healthcare Limited, CROOKES
Children under 14 years Do not use on children under 14 following treatment with ibuprofen These may consist of Nottingham. NG23AA. NU295. HEALTHCARE
Eumovate Eczema & Dermatitis
Cream ProductInformation.
Presentation: Cream containing
clobetasone butyrate 0.05% w/w
Uses:Short-termtreatmentandcontrol
of patches of eczema and dermatitis
including atopic eczema and primary
irritantandallergicdermatitis Dosage
and administration: Adults and
children,aged 12yearsandover Apply
sparingly to the affected area twice a
day for up to 7 days If the condition
improveswithin 7daysstoptreatment
Ifconditiondoesnotimproveinthefirst
7 daysorbecomesworse, orifafter7
daystreatmentanimprovementisseen
but further treatment is required, the
patient should be advised to consult a
doctor To be used in children under
12 years only on the advice of a
doctor Contraindications: Known
hypersensitivity Broken skin or skin
lesionscausedbyinfectionwithviruses
(eg herpes simplex, chicken pox),
fungi (eg candidiasis, tinea) or
bacteria (eg impetigo) Acne vulgaris
Precautions: Absorption can be
increased by occlusion so treatment is
limited to no more than 7 days
continuous treatment without
occlusion Treatment should not be
initiatedatthesamesiteforathirdtime
without medical advice Only to be
used for the treatment of eczema or
dermatitis as other conditions may be
masked orexacerbated. Should notbe
used on the face, groins, genitals or
between the toes Medical advice
should be sought in seborrhoeic
eczema. Consumersshould bewarned
against letting the cream get into the
eye, as topical steroids can cause
glaucoma. Do not use with other Before gets to
this,
topical corticosteroids or in the it
treatmentofpsoriasis Pregnancyand
lactation: Useonlyon theadviceofa get to them
doctor Side effects: Hypersensitivity.
Exacerbation of symptoms Legal
category:P Productlicencenumber:
10949/0346 Product licence holder:
GlaxoSmithKlineConsumerHealthcare, Skin Flare-Up due to eczema and dermatitis, characterised by itchy, red
Brentford, TW8 9GS Further
information available on request dry and inflamed skin, can be extremely aggravating. Eumovate Eczema
from: Medical and Consumer Affairs, & Dermatitis Cream, available without prescription, acts early and help:
GlaxoSmithKline Consumer Healthcare,
Wallis House, Great West Road, break the Itch-Scratch Cycle, before gets out of control.
it
Brentford, Middlesex, TW8 9BD
PackagequantityandRSP: 15gtube No other over-the-counter medicine clears Skin Flare-Up more
-£549 Dateofpreparation:August effectively than Eumovate Eczema & Dermatitis Cream.12
2001. Eumovate is a registered
trademark of the GlaxoSmithKline
GroupofCompanies
©GlaxoSmithKlineUKLimited, 2001 for Skin Flare-Up
References:
1 MunroDD,WilsonL. BrMedJ WWWWWWWWeumovate
1975,3 626-8 www
WWWW
2 Parneix-SpakeA, GoustasP, eczema & dermatitis cream
w
GreenR. JDermatolTreat[Inpress). clobetasone butyrate 0.05%
Cl.xoSirathKlme over to you